Compare $AEON vs $TPST | Chartloom

Compare

$AEON vs $TPST

AEON Biopharma Inc · Tempest Therapeutics Inc

AEON

AEON Biopharma Inc

TPST

Tempest Therapeutics Inc

Compare $AEON vs $TPST

Comparing AEON Biopharma Inc and Tempest Therapeutics Inc

AEONAEON Biopharma Inc

TPSTTempest Therapeutics Inc

AEONAEON Biopharma Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-75.1%

52W performance

-70.0%

FCF yield

-133.0%

TPSTTempest Therapeutics Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-6.3%

YTD performance

-74.2%

52W performance

-93.1%

FCF yield

-170.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AEON

TPST

Detailed metrics comparison

AEON

AEON Biopharma Inc

TPST

Tempest Therapeutics Inc

Market Cap

AEON$10M

TPST$12M

Enterprise Value

AEON$9M

TPST$11M

Price

AEON$0.28

TPST$0.76

P/E Ratio

AEONN/A

TPSTN/A

P/S Ratio

AEON0.00x

TPST45.67x

EV/Sales

AEON0.00x

TPST43.07x

EV/EBITDA

AEON0.08x

TPST0.00x

P/B Ratio

AEON4.90x

TPST16.67x

P/FCF Ratio

AEONN/A

TPSTN/A

EV/FCF

AEON-0.63x

TPST-0.55x

PEG Ratio

AEONN/A

TPSTN/A

Forward P/E (NTM)

AEONN/A

TPSTN/A

Forward P/S (NTM)

AEONN/A

TPSTN/A

Revenue (TTM)

AEON$0

TPST$0

Revenue Growth (YoY)

AEONN/A

TPST-6.3%

Forward Rev Growth

AEON3564.8%

TPST0.0%

Gross Margin (TTM)

AEON0.0%

TPST0.0%

Operating Margin (TTM)

AEON0.0%

TPST0.0%

EBITDA Margin (TTM)

AEON0.0%

TPST0.0%

Net Margin (TTM)

AEON0.0%

TPST0.0%

FCF Margin (TTM)

AEONN/A

TPSTN/A

Net Income (TTM)

AEON$-55M

TPST$-40M

FCF (TTM)

AEON$-14M

TPST$-21M

EPS (TTM)

AEON-$1.08

TPST-$2.66

ROE (TTM)

AEON-174.1%

TPST-72989.0%

ROA (TTM)

AEON-75776.0%

TPST-29736.0%

ROIC (TTM)

AEON-180.4%

TPST-72989.0%

Cash

AEON$3M

TPST$779K

Debt

AEON$2M

TPST$0

Net Cash/Debt

AEON$2M

TPST$779K

Current Ratio (TTM)

AEON0.54x

TPST0.38x

Quick Ratio (TTM)

AEON0.47x

TPST0.27x

Debt/Equity (TTM)

AEON10.28x

TPST0.00x

Debt/Assets (TTM)

AEON0.0%

TPST0.0%

Interest Coverage (TTM)

AEONN/A

TPSTN/A

Net Debt/EBITDA (TTM)

AEON0.00x

TPST0.00x

Beta

AEON0.64

TPST-1.61

52W Performance

AEON-70.0%

TPST-93.1%

YTD Performance

AEON-75.1%

TPST-74.2%

% from 52W High

AEON-81.0%

TPST-93.8%

% from 52W Low

AEON55.8%

TPST2.3%

Asset Turnover (TTM)

AEON0.00x

TPST0.01x

FCF Yield (TTM)

AEON-133.0%

TPST-170.7%

Earnings Yield (TTM)

AEON-532.7%

TPST-333.2%

Dividend Yield (TTM)

AEONN/A

TPSTN/A

Rule of 40

AEON0.0

TPST-6.3

EV/GP/RG

AEONN/A

TPSTN/A

Ticker research

View AEON research View TPST research

Metric	AEON AEON Biopharma Inc	TPST Tempest Therapeutics Inc
Market & Valuation
Market Cap	$10M	$12M
Enterprise Value	$9M	$11M
Price	$0.28	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	45.67x
EV/Sales	0.00x	43.07x
EV/EBITDA	0.08x	0.00x
P/B Ratio	4.90x	16.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.63x	-0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-6.3%
Forward Rev Growth	3564.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-55M	$-40M
FCF (TTM)	$-14M	$-21M
EPS (TTM)	-$1.08	-$2.66
ROE (TTM)	-174.1%	-72989.0%
ROA (TTM)	-75776.0%	-29736.0%
ROIC (TTM)	-180.4%	-72989.0%
Financial Health
Cash	$3M	$779K
Debt	$2M	$0
Net Cash/Debt	$2M	$779K
Current Ratio (TTM)	0.54x	0.38x
Quick Ratio (TTM)	0.47x	0.27x
Debt/Equity (TTM)	10.28x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.64	-1.61
52W Performance	-70.0%	-93.1%
YTD Performance	-75.1%	-74.2%
% from 52W High	-81.0%	-93.8%
% from 52W Low	55.8%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-133.0%	-170.7%
Earnings Yield (TTM)	-532.7%	-333.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-6.3
EV/GP/RG	N/A	N/A
Ticker research	View AEON research	View TPST research

Valuation

P/S Ratio

AEON

0.00x

TPST

45.67x

EV/FCF

AEON

-0.63x

TPST

-0.55x

Growth & revenue

Revenue Growth TTM

TPST

-6.3%

Forward Revenue Growth

AEON

3564.8%

TPST

0.0%

Profitability & performance

Gross Margin

AEON

0.0%

TPST

0.0%

ROE

AEON

-174.1%

TPST

-72989.0%

FCF Yield %

AEON

-133.0%

TPST

-170.7%

52-Week Performance

AEON

-70.0%

TPST

-93.1%

Detailed metrics comparison

AEON

AEON Biopharma Inc

TPST

Tempest Therapeutics Inc

Market Cap

AEON$10M

TPST$12M

Enterprise Value

AEON$9M

TPST$11M

Price

AEON$0.28

TPST$0.76

P/E Ratio

AEONN/A

TPSTN/A

P/S Ratio

AEON0.00x

TPST45.67x

EV/Sales

AEON0.00x

TPST43.07x

EV/EBITDA

AEON0.08x

TPST0.00x

P/B Ratio

AEON4.90x

TPST16.67x

P/FCF Ratio

AEONN/A

TPSTN/A

EV/FCF

AEON-0.63x

TPST-0.55x

PEG Ratio

AEONN/A

TPSTN/A

Forward P/E (NTM)

AEONN/A

TPSTN/A

Forward P/S (NTM)

AEONN/A

TPSTN/A

Revenue (TTM)

AEON$0

TPST$0

Revenue Growth (YoY)

AEONN/A

TPST-6.3%

Forward Rev Growth

AEON3564.8%

TPST0.0%

Gross Margin (TTM)

AEON0.0%

TPST0.0%

Operating Margin (TTM)

AEON0.0%

TPST0.0%

EBITDA Margin (TTM)

AEON0.0%

TPST0.0%

Net Margin (TTM)

AEON0.0%

TPST0.0%

FCF Margin (TTM)

AEONN/A

TPSTN/A

Net Income (TTM)

AEON$-55M

TPST$-40M

FCF (TTM)

AEON$-14M

TPST$-21M

EPS (TTM)

AEON-$1.08

TPST-$2.66

ROE (TTM)

AEON-174.1%

TPST-72989.0%

ROA (TTM)

AEON-75776.0%

TPST-29736.0%

ROIC (TTM)

AEON-180.4%

TPST-72989.0%

Cash

AEON$3M

TPST$779K

Debt

AEON$2M

TPST$0

Net Cash/Debt

AEON$2M

TPST$779K

Current Ratio (TTM)

AEON0.54x

TPST0.38x

Quick Ratio (TTM)

AEON0.47x

TPST0.27x

Debt/Equity (TTM)

AEON10.28x

TPST0.00x

Debt/Assets (TTM)

AEON0.0%

TPST0.0%

Interest Coverage (TTM)

AEONN/A

TPSTN/A

Net Debt/EBITDA (TTM)

AEON0.00x

TPST0.00x

Beta

AEON0.64

TPST-1.61

52W Performance

AEON-70.0%

TPST-93.1%

YTD Performance

AEON-75.1%

TPST-74.2%

% from 52W High

AEON-81.0%

TPST-93.8%

% from 52W Low

AEON55.8%

TPST2.3%

Asset Turnover (TTM)

AEON0.00x

TPST0.01x

FCF Yield (TTM)

AEON-133.0%

TPST-170.7%

Earnings Yield (TTM)

AEON-532.7%

TPST-333.2%

Dividend Yield (TTM)

AEONN/A

TPSTN/A

Rule of 40

AEON0.0

TPST-6.3

EV/GP/RG

AEONN/A

TPSTN/A

Ticker research

View AEON research View TPST research

Metric	AEON AEON Biopharma Inc	TPST Tempest Therapeutics Inc
Market & Valuation
Market Cap	$10M	$12M
Enterprise Value	$9M	$11M
Price	$0.28	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	45.67x
EV/Sales	0.00x	43.07x
EV/EBITDA	0.08x	0.00x
P/B Ratio	4.90x	16.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.63x	-0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-6.3%
Forward Rev Growth	3564.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-55M	$-40M
FCF (TTM)	$-14M	$-21M
EPS (TTM)	-$1.08	-$2.66
ROE (TTM)	-174.1%	-72989.0%
ROA (TTM)	-75776.0%	-29736.0%
ROIC (TTM)	-180.4%	-72989.0%
Financial Health
Cash	$3M	$779K
Debt	$2M	$0
Net Cash/Debt	$2M	$779K
Current Ratio (TTM)	0.54x	0.38x
Quick Ratio (TTM)	0.47x	0.27x
Debt/Equity (TTM)	10.28x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.64	-1.61
52W Performance	-70.0%	-93.1%
YTD Performance	-75.1%	-74.2%
% from 52W High	-81.0%	-93.8%
% from 52W Low	55.8%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-133.0%	-170.7%
Earnings Yield (TTM)	-532.7%	-333.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-6.3
EV/GP/RG	N/A	N/A
Ticker research	View AEON research	View TPST research